Alphyn Biologics

Biotechnology · Science & Engineering

Overview

Striving for theFirst Complete Atopic DermatitisTreatment. Zabalafin hydrogel (AB-101a) is in development to uniquely solve the critical challenges associated with treating mild-to-moderate atopic dermatitis (AD), the most common form of eczema.

Funding and backers

Total raised
$8.5M
4 rounds on record
Latest round
$5.2M
Venture round · Mar 2024 · 2 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 28, 2024 Raised a round Venture round $5.2M · SEC Form D May 19, 2023 Raised a round Venture round $1.2M · SEC Form D May 19, 2022 Raised a round Venture round $2.2M · SEC Form D Jan 27, 2020 Took on debt financing $800k · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2024 $5.2M — SEC Form D
Venture round May 2023 $1.2M — SEC Form D
Venture round May 2022 $2.2M — SEC Form D
Debt Financing Jan 2020 $800k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Alphyn Biologics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Neal KollerExecutive Officer, DirectorSEC Form D
Gary PekoeExecutive Officer, DirectorSEC Form D
Steven PentelnikExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Soteri Skin
SOSV
backs Serene Sleep
E14 Fund
backs Serene Sleep
OrbiMed
backs Belenos Bio
Elemental Impact
backs Noon Energy
Clean Energy Ventures
backs Noon Energy
Similar startupsby what they do, their industry and backers
Belenos Bio
We believe that clinical remission should be the standard—not the exception—for treating chronic inflammatory diseases like COPD, asthma…
Airsonett
Airsonett offers effective treatment of allergic asthma and atopic dermatitis – no pharmacological side effects. 99,5% allergen-free air…
Serene Sleep11-50 employees
Serene Sleep. Simple 15-minute palatal implant procedure for snoring and mild-to-moderate obstructive sleep apnea. No masks, no mouth tape…
Soteri Skin
The Only Clinically Tested Eczema Skincare Treatment that Offers Long-Term Eczema Relief.
Dose InsightVenture round $103k · 23 mo ago · Founded 2022
Our Story Dose Insight was founded by an established team of physicists, engineers, and entrepreneurs. Throughout our decades working in…
Noon EnergyVenture round $28M · 3 yr ago · Founded 2018 · 51-200 employees · 1 role
Top of page Our Mission Reliable, resilient energy independence Noon Energy was founded to solve one of the most critical challenges facing…

Financials

Total raised
$9.3M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $5.2M Details
Venture - Series Unknown 2023 $1.2M Details
Venture - Series Unknown 2022 $2.2M Details
Debt Financing 2020 $800k Details

People

Neal Koller
Executive Officer, Director
SEC Form D
Gary Pekoe
Executive Officer, Director
SEC Form D
Steven Pentelnik
Executive Officer
SEC Form D
Roger Griggs
Director
SEC Form D
Jeffrey Kossak
Director
SEC Form D
Adel Mikhail
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Annapolis United States
HQ
10-50 est. staff